2012 Publications

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | < 1999

  • Backhed F., Fraser C.M., Ringel Y., Sanders M.E., Sartor R.B., Sherman P.M., Versolovic J., Young V., Finlay BB. (Nov) 2012. Defining a healthy human gut microbiome: Current concepts, future directions and clinical applications. Cell-Host Microbe. 2012 Nov 15;12(5):611-22.
  • Gill N., Ferreira R.B., Antunes L.C., Willing B.P., Sekirov I., Al-Zahrani F., Hartmann M., Finlay BB. (Oct) 2012. Neutrophil elastase alters the gut microbiota resulting in enhanced Salmonella colonization. PLoS One, 2012;7(11):e49646.
  • Kumar N.S., Amandoron E.A., Cherkasov A., Finlay BB., Gong H., Jackson L., Kaur W., Lian T., Moreau A., Labriere C., Reiner N.E., See R.H., Strynadka N.C., Thorson L., Wong E.W., Worral L., Zoraghi R., Young R.N. (Dec) 2012. Optimization and structure-activity relationships of a series of potent inhibitors of methicillin-resistant Staphylococcus aureus (MRSA) pyruvate kinase as novel antimicrobial agents. Bioorg Med Chem. 2012 Dec 15;20(24):7069-82.
  • Menendez A., Willing B.P., Montero M., Wlodarska M., So C.C., Bhiner G., Vallance B.A., Finlay BB. (Sept) 2012. Bacterial stimulation of the TLR-MyD88 pathway modulates the homeostatic expression of ileal paneth cell α-Defensins. J Innate Immun. 2013;5(1):39-49.
  • Karch H., Denamur E., Dobrindt U., Finlay BB., Hengge R., Johannes L., Ron E.Z., Tonjum T., Sansonetti P.J., Vicente M.(Sept) 2012. The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol Med. 2012 Sep;4(9):841-8.
  • Prehna G., Li Y., Stoynov N., Okon M., Vukovic M., McIntosh L.P., Foster L.J., Finlay BB., Stynadka N.C. (Sept) 2012. The Zinc Regulated Antivirulence Pathway of Salmonella is a Multi-protein Immunoglobulin Adhesion System. J Biol Chem.2012 Sep 21;287(39):32324-37.
  • Cortés-Vieyra R., Bravo-Patiño A., Valdez-Alarcón J.J., Cajero-Juárez M., Finlay BB., Baizabal-Aguirre V.M. (June) 2012. Role of glycogen synthase kinase-3 beta in the inflammatory response caused by bacterial pathogens. J Inflamm (Lond). 2012 Jun 12;9(1):23.
  • Russell, S., Finlay BB. (Oct) 2012. The impact of gut microbes in allergic diseases. Curr Opin Gastroenterol, 2012 Nov;28(6):563-9. (Review)
  • Deng W., Yu H.B., de Hoog C.L., Stoynov N., Li Y., Foster L.J., Finlay BB. (Sept) 2012. Quantitative proteomic analysis of type III secretome of enteropathogenic Escherichia coli reveals an expanded effector repertoire for attaching/effacing bacterial pathogens. Mol Cell Proteomics. 2012 Sep;11(9):692-709.
  • van der Heijden, J., Finlay BB. (June) 2012. Type III effector-mediated processes in Salmonella infection. Future Microbiol. 2012 Jun;7:685-703.
  • Arrieta M.C., Finlay BB. (June) 2012. The commensal microbiota drives immune homeostasis. Front Immunol. 2012;3:33.
  • Achtman, A.H., Pilat S., Law C.W., Lynn D.J., Janot L., Mayer M.L., Ma S., Kindrachuk J., Finlay BB., Brinkman F.S., Smyth G.K., Hancock R.E., Schofield L. (May) 2012. Effective adjunctive therapy by an innate defense regulatory peptide in a pre-clinical model of severe malaria. Science Transl Med., 2012 May 23;4(135):135ra64.
  • Liu Z., Zaki M.H., Vogel P., Gurung P., Finlay BB., Deng W., Lamkanfi M., Kanneganti T.D. (Mar) 2012. The role of inflammasomes in host defense against Citrobacter rodentium infection. J Biol Chem. 2012 May 11;287(20):16955-64.
  • Sal-Man N., Biemans-Oldehinkel E. Sharon D., Croxen M.A., Scholz R., Foster L.J., Finlay BB. (Mar) 2012. EscA is a crucial component of the type III secretion system of enteropathogenic E. coli. J Bacteriol. 2012 Jun;194(11):2819-28.
  • Shames S.R., Finlay BB. (Mar) 2012. Bacterial effector interplay: a new way to view effector function. Trends Microbiol. 2012 May;20(5):214-9.
  • Russell S.L., Gold M.J., Hartmann M., Willing B.P., Thorson L., Wlodarska M., Gill N., Blanchet M.R., Mohn W.W., McNagny K.M., Finlay BB. (Mar) 2012. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012 May 1;13(5):440-7, includes cover.
  • Ferreira R.B., (NOV (Mar) 2012.Identifying an immune signature against invasive Salmonella. Proc Natl Acad Sci USA. 2012 Mar 27;109(13):4721-2.
  • Antunes L.C., Wang M., Andersen S.K., Ferreira R.B., Kappelhoff R., Han J., Borchers C.H., Finlay BB. (May) 2012. Repression of Salmonella enterica phoP expression by small molecules from physiological bile. J. Bacteriol., 2012 May;194(9):2286-96.
  • Sal-Man N., Deng W., Finlay BB. (Feb) 2011. Escl-a crucial component of the type III secretion system forms the inner rod structure in enteropathogenic Escherichia coli. Biochem J. 2012 Feb 15;442(1):119-25.